Adverum Biotechnologies, Inc. - FORM 10-K - EX-21.1 - March 1, 2021

Attached files

file filename
EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc.advm-20201231xexx311.htm
EX-23.1 - EX-23.1 - Adverum Biotechnologies, Inc.advm-20201231xexx231.htm
EX-32.2 - EX-32.2 - Adverum Biotechnologies, Inc.advm-20201231xexx322.htm
EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc.advm-20201231xexx321.htm
10-K - 10-K - Adverum Biotechnologies, Inc.advm-20201231.htm
EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc.advm-20201231xexx312.htm
EX-4.2 - EX-4.2 - Adverum Biotechnologies, Inc.advm-20201231xexx42.htm

Exhibit 21.1
SUBSIDIARIES OF ADVERUM BIOTECHNOLOGIES, INC.
Name of SubsidiaryCountry of Incorporation
Avalanche Australia PTY LTDAustralia
Annapurna Therapeutics, LTDIreland
Adverum NC, LLCNorth Carolina, USA




Adverum Biotechnologies, Inc. Reports